Trial Profile
Medications Development for Drug Abuse Disorders
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 21 Jul 2017
Price :
$35
*
At a glance
- Drugs Tramadol (Primary) ; Buprenorphine/naloxone; Clonidine
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 21 Jul 2017 Primary endpoint (Mean Ratings on Clinical Opiate Withdrawal Scale (COWS) Measure of Withdrawal During Double-blind Taper (7-days) and Post-taper (7-days) Period) has been met according to results published in the JAMA Psychiatry.
- 21 Jul 2017 New trial record
- 12 Jul 2017 Results published in the JAMA Psychiatry